| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |